Unicycive Therapeutics Changes Fiscal Year End

Ticker: UNCY · Form: 8-K · Filed: Jun 26, 2024 · CIK: 1766140

Unicycive Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyUnicycive Therapeutics, Inc. (UNCY)
Form Type8-K
Filed DateJun 26, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: fiscal-year-change, reporting-update

TL;DR

Unicycive just changed its fiscal year end to June 30th, effective now. New reporting cycle starts July 1st.

AI Summary

On June 21, 2024, Unicycive Therapeutics, Inc. filed an 8-K report detailing a change in its fiscal year end from December 31st to June 30th, effective immediately. This change will result in a short fiscal year ending on June 30, 2024, followed by a regular fiscal year beginning July 1, 2024. The company's principal executive offices are located at 4300 El Camino Real, Suite 210, Los Altos, CA 94022.

Why It Matters

This change in fiscal year end could impact the timing of financial reporting and potentially align the company's reporting cycle with industry peers or operational milestones.

Risk Assessment

Risk Level: low — The filing solely concerns an administrative change in the company's fiscal year end, with no immediate financial or operational implications disclosed.

Key Players & Entities

  • Unicycive Therapeutics, Inc. (company) — Registrant
  • June 21, 2024 (date) — Date of earliest event reported
  • June 30 (date) — New fiscal year end
  • July 1, 2024 (date) — Start of new regular fiscal year
  • 4300 El Camino Real, Suite 210, Los Altos, CA 94022 (address) — Principal executive offices

FAQ

What is the new fiscal year end for Unicycive Therapeutics, Inc.?

The new fiscal year end for Unicycive Therapeutics, Inc. is June 30.

When is this change in fiscal year end effective?

The change in fiscal year end is effective immediately as of June 21, 2024.

What will be the duration of the short fiscal year ending in 2024?

The filing indicates a short fiscal year ending on June 30, 2024.

When will the next regular fiscal year begin for Unicycive Therapeutics?

The next regular fiscal year will begin on July 1, 2024.

What is the principal executive office address for Unicycive Therapeutics?

The principal executive office address is 4300 El Camino Real, Suite 210, Los Altos, CA 94022.

Filing Stats: 527 words · 2 min read · ~2 pages · Grade level 13.2 · Accepted 2024-06-26 17:20:41

Filing Documents

01 Financial Statements

Item 9.01 Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 3.1 Certificate of Amendment 104 Cover Page Interactive Data File (embedded with the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 26, 2024 UNICYCIVE THERAPEUTICS, INC. By: /s/ Shalabh Gupta Shalabh Gupta Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.